ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 437,33
0,39%
Dow Jones
42 505,01
0,49%
DAX
20 261,71
0,62%
Brent Oil
79,745
-0,67%
Bitcoin
96 600,03
2,21%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. King Pharmaceuticals, Inc. (KG)

  7. King Pharmaceuticals, Inc. (KG) Actualités

KG

King (KG)

King Pharmaceuticals, Inc.
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:KG
DateHeureSourceTitreSymboleSociété
24/02/201112h00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)NYSE:KGKing Pharmaceuticals, Inc.
23/02/201122h40Edgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)NYSE:KGKing Pharmaceuticals, Inc.
22/02/201123h06Edgar (US Regulatory)Current report filing (8-K)NYSE:KGKing Pharmaceuticals, Inc.
18/02/201122h09Edgar (US Regulatory)Post-effective Amendment to an automatic shelf registration of Form S-3ASR or Form F-3ASR (POSASR)NYSE:KGKing Pharmaceuticals, Inc.
18/02/201122h05Edgar (US Regulatory)Post-Effective Amendment to Registration Statement (POS AM)NYSE:KGKing Pharmaceuticals, Inc.
18/02/201122h02Edgar (US Regulatory)-National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25)NYSE:KGKing Pharmaceuticals, Inc.
15/02/201123h03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:KGKing Pharmaceuticals, Inc.
15/02/201117h57Edgar (US Regulatory)Statement of Ownership (SC 13G)NYSE:KGKing Pharmaceuticals, Inc.
14/02/201119h52Edgar (US Regulatory)Schedule 13GNYSE:KGKing Pharmaceuticals, Inc.
10/02/201120h36Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NYSE:KGKing Pharmaceuticals, Inc.
10/02/201112h08Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NYSE:KGKing Pharmaceuticals, Inc.
10/02/201100h08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:KGKing Pharmaceuticals, Inc.
08/02/201115h32MarketwiredKing Pharmaceuticals, Inc. Announces Intent to Voluntarily Delist From the New York Stock ExchangeNYSE:KGKing Pharmaceuticals, Inc.
31/01/201122h23Edgar (US Regulatory)Tender offer statement by Issuer (SC TO-I)NYSE:KGKing Pharmaceuticals, Inc.
31/01/201122h05MarketwiredKing Pharmaceuticals, Inc. Announces Offer to Purchase Any and All of Its Outstanding 1 1/4% Convertible Senior Notes Due 2026 TNYSE:KGKing Pharmaceuticals, Inc.
31/01/201115h20Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NYSE:KGKing Pharmaceuticals, Inc.
31/01/201115h06Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NYSE:KGKing Pharmaceuticals, Inc.
27/01/201114h45PR Newswire (US)REMOXY® New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011NYSE:KGKing Pharmaceuticals, Inc.
25/01/201115h59PR Newswire (US)Zacks Analyst Blog Highlights: Pfizer, King Pharmaceuticals, Durect Pharma, Pain Therapeutics and Acura PharmaceuticalsNYSE:KGKing Pharmaceuticals, Inc.
21/01/201115h25Dow Jones NewsPfizer Again Extends Offer For King Pharma; Fewer Shares TenderedNYSE:KGKing Pharmaceuticals, Inc.
21/01/201100h06Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)NYSE:KGKing Pharmaceuticals, Inc.
27/12/201014h30GlobeNewswire Inc.King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY(R)NYSE:KGKing Pharmaceuticals, Inc.
27/12/201013h58Dow Jones NewsKing Pharma Resubmits FDA Application For RemoxyNYSE:KGKing Pharmaceuticals, Inc.
27/12/201013h15PR Newswire (US)REMOXY® New Drug Application ResubmittedNYSE:KGKing Pharmaceuticals, Inc.
27/12/201013h00PR Newswire (US)King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY®NYSE:KGKing Pharmaceuticals, Inc.
20/12/201014h59MarketwiredBrian Markison to Join Rosetta Genomics Board of DirectorsNYSE:KGKing Pharmaceuticals, Inc.
20/12/201013h00PR Newswire (US)King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New Drug Application for ACUROX® TabletsNYSE:KGKing Pharmaceuticals, Inc.
16/12/201021h25Dow Jones NewsS&P 500 Rings In New Year With Higher-Tech, Larger-Cap NamesNYSE:KGKing Pharmaceuticals, Inc.
15/12/201023h45Dow Jones NewsPfizer Again Extends Deadline On King Tender OfferNYSE:KGKing Pharmaceuticals, Inc.
15/12/201023h01PR Newswire (US)Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc.NYSE:KGKing Pharmaceuticals, Inc.
 Showing the most relevant articles for your search:NYSE:KG

Dernières Valeurs Consultées

COIN
BTCUSD
Bitcoin
EU
MC
Lvmh Moet Hennessy Louis...
FTSE
UKX
FTSE 100
NASDAQ
AAPL
Apple
EU
BEL20
Bel 20
EU
EN
Bouygues
EU
RI
Pernod Ricard
NYSE
DIS
Walt Disney
EU
PX4
SBF 120
COIN
AVAXUSD
Avalanche
EU
ACA
Credit Agricole
EU
VK
Vallourec
EU
GLE
Societe Generale
EU
DG
Vinci
COIN
ADAUSD
Cardano
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés